CHST15
Basic information
Region (hg38): 10:124007668-124093598
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHST15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 29 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 29 | 1 | 4 |
Variants in CHST15
This is a list of pathogenic ClinVar variants found in the CHST15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-124010178-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
10-124010192-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
10-124010243-A-C | not specified | Uncertain significance (May 29, 2024) | ||
10-124010277-G-T | not specified | Uncertain significance (Apr 06, 2022) | ||
10-124021236-CG-C | Benign (Feb 23, 2021) | |||
10-124021266-T-C | not specified | Uncertain significance (May 16, 2023) | ||
10-124021288-C-T | not specified | Uncertain significance (May 30, 2024) | ||
10-124021293-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
10-124021296-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
10-124021341-T-A | not specified | Uncertain significance (Dec 13, 2022) | ||
10-124021363-C-T | not specified | Uncertain significance (Jul 31, 2024) | ||
10-124021369-C-T | not specified | Uncertain significance (Mar 28, 2023) | ||
10-124038592-C-T | Benign (Apr 04, 2018) | |||
10-124038598-C-A | not specified | Uncertain significance (Feb 23, 2023) | ||
10-124038603-C-T | not specified | Uncertain significance (Sep 09, 2024) | ||
10-124038629-G-A | not specified | Uncertain significance (Nov 19, 2024) | ||
10-124038636-C-A | not specified | Uncertain significance (Jun 16, 2024) | ||
10-124042369-T-C | not specified | Uncertain significance (Dec 19, 2022) | ||
10-124042373-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
10-124042411-T-G | not specified | Uncertain significance (Dec 17, 2021) | ||
10-124042414-C-T | not specified | Uncertain significance (Nov 23, 2024) | ||
10-124042438-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
10-124044619-C-A | not specified | Uncertain significance (Aug 19, 2024) | ||
10-124044654-T-C | not specified | Uncertain significance (May 30, 2023) | ||
10-124044734-G-C | not specified | Uncertain significance (Nov 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHST15 | protein_coding | protein_coding | ENST00000346248 | 7 | 86023 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000352 | 0.989 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.32 | 280 | 349 | 0.802 | 0.0000222 | 3735 |
Missense in Polyphen | 48 | 87.7 | 0.54732 | 953 | ||
Synonymous | 0.387 | 143 | 149 | 0.960 | 0.0000108 | 1039 |
Loss of Function | 2.27 | 11 | 22.7 | 0.485 | 0.00000113 | 261 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000242 | 0.000239 |
Ashkenazi Jewish | 0.0000999 | 0.0000992 |
East Asian | 0.0000587 | 0.0000544 |
Finnish | 0.0000930 | 0.0000924 |
European (Non-Finnish) | 0.000108 | 0.000105 |
Middle Eastern | 0.0000587 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that transfers sulfate from 3'- phosphoadenosine 5'-phosphosulfate (PAPS) to the C-6 hydroxyl group of the GalNAc 4-sulfate residue of chondroitin sulfate A and forms chondroitin sulfate E containing GlcA-GalNAc(4,6-SO(4)) repeating units. It also transfers sulfate to a unique non- reducing terminal sequence, GalNAc(4SO4)-GlcA(2SO4)-GalNAc(6SO4), to yield a highly sulfated structure similar to the structure found in thrombomodulin chondroitin sulfate. May also act as a B- cell receptor involved in BCR ligation-mediated early activation that mediate regulatory signals key to B-cell development and/or regulation of B-cell-specific RAG expression; however such results are unclear in vivo. {ECO:0000269|PubMed:11572857, ECO:0000269|PubMed:12874280}.;
- Pathway
- Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human);Metabolism of carbohydrates;Chondroitin sulfate biosynthesis;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;dermatan sulfate biosynthesis (late stages);chondroitin sulfate biosynthesis (late stages);chondroitin sulfate biosynthesis;dermatan sulfate biosynthesis;Metabolism;BCR
(Consensus)
Intolerance Scores
- loftool
- 0.156
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 47.12
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.605
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.708
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chst15
- Phenotype
- hematopoietic system phenotype; reproductive system phenotype; immune system phenotype;
Gene ontology
- Biological process
- hexose biosynthetic process;chondroitin sulfate biosynthetic process
- Cellular component
- Golgi membrane;integral component of membrane
- Molecular function
- 3'-phosphoadenosine 5'-phosphosulfate binding;N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity